KROS
Price
$13.53
Change
-$0.88 (-6.11%)
Updated
Aug 7, 10:42 AM (EDT)
Capitalization
585.27M
84 days until earnings call
SXTP
Price
$1.33
Change
-$0.01 (-0.74%)
Updated
Aug 7, 10:55 AM (EDT)
Capitalization
4.34M
6 days until earnings call
Interact to see
Advertisement

KROS vs SXTP

Header iconKROS vs SXTP Comparison
Open Charts KROS vs SXTPBanner chart's image
Keros Therapeutics
Price$13.53
Change-$0.88 (-6.11%)
Volume$500
Capitalization585.27M
60 Degrees Pharmaceuticals
Price$1.33
Change-$0.01 (-0.74%)
Volume$100
Capitalization4.34M
KROS vs SXTP Comparison Chart in %
Loading...
KROS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SXTP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KROS vs. SXTP commentary
Aug 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KROS is a Hold and SXTP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 07, 2025
Stock price -- (KROS: $14.41 vs. SXTP: $1.35)
Brand notoriety: KROS and SXTP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KROS: 73% vs. SXTP: 20%
Market capitalization -- KROS: $585.27M vs. SXTP: $4.34M
KROS [@Biotechnology] is valued at $585.27M. SXTP’s [@Biotechnology] market capitalization is $4.34M. The market cap for tickers in the [@Biotechnology] industry ranges from $210.97B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KROS’s FA Score shows that 1 FA rating(s) are green whileSXTP’s FA Score has 1 green FA rating(s).

  • KROS’s FA Score: 1 green, 4 red.
  • SXTP’s FA Score: 1 green, 4 red.
According to our system of comparison, KROS is a better buy in the long-term than SXTP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KROS’s TA Score shows that 6 TA indicator(s) are bullish while SXTP’s TA Score has 6 bullish TA indicator(s).

  • KROS’s TA Score: 6 bullish, 4 bearish.
  • SXTP’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, SXTP is a better buy in the short-term than KROS.

Price Growth

KROS (@Biotechnology) experienced а -0.41% price change this week, while SXTP (@Biotechnology) price change was -2.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.68%. For the same industry, the average monthly price growth was +9.93%, and the average quarterly price growth was +14.10%.

Reported Earning Dates

KROS is expected to report earnings on Oct 30, 2025.

SXTP is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+2.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KROS($585M) has a higher market cap than SXTP($4.34M). KROS YTD gains are higher at: -8.970 vs. SXTP (-79.147). KROS has higher annual earnings (EBITDA): 14.8M vs. SXTP (-10.19M). KROS has more cash in the bank: 721M vs. SXTP (3.45M). SXTP has less debt than KROS: SXTP (155K) vs KROS (18.4M). KROS has higher revenues than SXTP: KROS (215M) vs SXTP (665K).
KROSSXTPKROS / SXTP
Capitalization585M4.34M13,482%
EBITDA14.8M-10.19M-145%
Gain YTD-8.970-79.14711%
P/E RatioN/AN/A-
Revenue215M665K32,331%
Total Cash721M3.45M20,886%
Total Debt18.4M155K11,871%
TECHNICAL ANALYSIS
Technical Analysis
KROSSXTP
RSI
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
70%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
88%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
86%
MACD
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 11 days ago
80%
Bullish Trend 3 days ago
87%
Declines
ODDS (%)
Bearish Trend 8 days ago
80%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
KROS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SXTP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCNAX45.83N/A
N/A
Fidelity Advisor Consumer Discret A
OSTFX19.72N/A
N/A
Osterweis
FQITX13.39N/A
N/A
Fidelity SAI International Qly Idx
VKSFX10.54N/A
N/A
Virtus KAR Small-Mid Cap Value I
TMPIX55.44N/A
N/A
Touchstone Mid Cap Institutional

KROS and

Correlation & Price change

A.I.dvisor indicates that over the last year, KROS has been loosely correlated with INO. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if KROS jumps, then INO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KROS
1D Price
Change %
KROS100%
+0.14%
INO - KROS
53%
Loosely correlated
-1.35%
AXON - KROS
43%
Loosely correlated
-0.40%
RAPT - KROS
39%
Loosely correlated
-1.09%
DNLI - KROS
39%
Loosely correlated
+0.42%
ALT - KROS
39%
Loosely correlated
-1.91%
More

SXTP and

Correlation & Price change

A.I.dvisor tells us that SXTP and XFOR have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SXTP and XFOR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SXTP
1D Price
Change %
SXTP100%
-2.54%
XFOR - SXTP
24%
Poorly correlated
-1.86%
CLDX - SXTP
23%
Poorly correlated
-3.12%
KROS - SXTP
22%
Poorly correlated
+0.14%
ABSI - SXTP
22%
Poorly correlated
-1.36%
VIGL - SXTP
21%
Poorly correlated
N/A
More